Abstract
Neurodegeneration, a progressive disease due to the arrested development of atrophy and regression of neuron function, is the most common disorder people go through. The treatment of the disease is generally symptomatic, and after a certain time, the effectivity of the drug decreases. A less toxic compound, vitamin K, a lipophilic (fat-soluble) vitamin, shows some promising results. Generally, vitamin K is found in three different forms: phylloquinone (vitamin K1) from green vegetables, menaquinone (vitamin K2) from anaerobic bacteria, and synthetic analog menadione (vitamin K3). The biological activities of each form of vitamin K differ from each other. Vitamin K1 is mainly stored in the liver and has a more prominent role in forming coagulation proteins. On the other hand, vitamin K2 is widely dispersed throughout the human body. Here in this review, the therapeutic role of vitamin K in different disorders, mainly focusing the neurological disorders, including neuroinflammation, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, is discussed. As a limited number of laboratories are involved in understanding vitamin K as a neuroprotective agent, the review will encourage further exploration in validating the neuroprotective effects of vitamin K among the pharmacognostic community.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Rahman MS, Alkady EA, Ahmed S (2015) Menaquinone-7 as a novel pharmacological therapy in treating rheumatoid arthritis: a clinical study. Eur J Pharmacol 761:273–278. https://doi.org/10.1016/j.ejphar.2015.06.014
Allison AC (2001) The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses 57:151–155. https://doi.org/10.1054/mehy.2001.1307
Aoun M, Makki M, Azar H, Matta H, Chelala DN (2017) High dephosphorylated-uncarboxylated MGP in hemodialysis patients: risk factors and response to vitamin K2, a pre-post intervention clinical trial. BMC Nephrol 18:191. https://doi.org/10.1186/s12882-017-0609-3
Azuma K, Osuka Y, Kojima N, Sasai H, Kim H, Inoue S (2022) Association of vitamin K insufficiency with cognitive dysfunction in community-dwelling older adults. Front Nutr 8:811831. 10.3389%2Ffnut.2021.811831
Basset GJ, Latimer S, Fatihi A, Soubeyrand E, Block A (2017) Phylloquinone (vitamin K1): occurrence, biosynthesis and functions. Mini-Rev Med Chem 17:1028–1038. https://doi.org/10.2174/1389557516666160623082714
Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-synuclein oligomers: a new hope. Acta Neuropathol 134:819–838. https://doi.org/10.1007/s00401-017-1755-1
Berkner KL (2008) Vitamin K-dependent carboxylation. Vitam Horm 78:131–156. https://doi.org/10.1016/S0083-6729(07)00007-6
Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, Van Der Schouw YT (2009) High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 203:489–493. https://doi.org/10.1016/j.atherosclerosis.2008.07.010
Beulens JW, Van Der ADL, Grobbee DE, Sluijs I, Spijkerman AM, Van Der Schouw YT (2010) Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 33:1699–1705. https://doi.org/10.2337/dc09-2302
Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C (2013) The role of menaquinones (vitamin K2) in human health. Br J Nutr 110:1357–1368. https://doi.org/10.1017/S0007114513001013
Booth SL, Suttie JW (1998) Dietary intake and adequacy of vitamin K. J Nutr 128:785–788. https://doi.org/10.1093/jn/128.5.785
Booth SL, Centi A, Smith SR, Gundberg C (2013) The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol 9:43–55. https://doi.org/10.1038/nrendo.2012.201
Cavazzoni P (2021) FDA’s decision to approve new treatment for Alzheimer’s disease. U.S. Food and Drug Administration. https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease. Accessed August 5, 2022
Chen LW, Chen W, Hu ZQ, Bian JL, Ying L, Hong GL, Qiu QM, Zhao GJ, Lu ZQ (2016) Protective effects of growth arrest-specific protein 6 (Gas 6) on sepsis-induced acute kidney injury. Inflammation 39:575–582. https://doi.org/10.1007/s10753-015-0282-2
Choi HJ, Yu J, Choi H, An JH, Kim SW, Park KS, Jang HC, Kim SY, Shin CS (2011) Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 34:e147-. https://doi.org/10.2337/dc11-0551
Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J, Cui L (2018) Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediators Inflamm 2018:8168717. https://doi.org/10.1155/2018/8168717
Clauser S, Meilhac O, Bièche I, Raynal P, Bruneval P, Michel JB, Borgel D (2021) Increased secretion of Gas 6 by smooth muscle cells in human atherosclerotic carotid plaques. J Thromb Haemost 107:140–149. https://doi.org/10.1160/TH11-05-0368
Cummings J, Lee G, Zhong K, Fonseca J, Taghva K (2021) Alzheimer’s disease drug development pipeline: 2021. Alzheimer’s Dement.: Transl Res Clin Interv 7:e12179. https://doi.org/10.1002/trc2.12179
da Silva FL, Cerqueira EC, de Freitas MS, Gonçalves DL, Costa LT, Follmer C (2013) Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein. J Neurochem 62:103–112. https://doi.org/10.1016/j.neuint.2012.10.001
Dasari S, Samy AL, Kajdacsy-Balla A, Bosland MC, Munirathinam G (2018) Vitamin K2, a menaquinone present in dairy products, targets castration-resistant prostate cancer cell-line by activating apoptosis signaling. Food Chem Toxicol 115:218–227. https://doi.org/10.1016/j.fct.2018.02.018
de Borst MH, Hill TR, Morrissey PA (2016) Vitamins: vitamin K. In: Fuquay JW (ed). Encyclopedia of dairy sciences, USA: Elsevier, pp. 661–666. https://doi.org/10.1016/B978-0-08-100596-5.01080-5
de Oliveira RB, Stinghen AE, Massy ZA (2020) Vitamin K role in mineral and bone disorder of chronic kidney disease. Clin Chim Acta 502:66–72. https://doi.org/10.1016/j.cca.2019.11.040
Dickson DW, Fujishiro H, Orr C, Delle Donne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009) Neuropathology of non-motor features of Parkinson’s disease. Parkinsonism Relat Disord 15:S1-5. https://doi.org/10.1016/S1353-8020(09)70769-2
Evans E, Piccio L, Cross AH (2018) Use of vitamins and dietary supplements by patients with multiple sclerosis: a review. Jama Neurol 75:1013–1021. https://doi.org/10.1001/jamaneurol.2018.0611
Fakhree NK, Mhaibes SH, Khalil HH (2021) Impact of vitamin K on human health. Iraqi J Pharm Sci 30:1–13. https://doi.org/10.31351/vol30iss1pp1-13
Farhadi Moghadam B, Fereidoni M (2020) Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia/reperfusion injury in the rat. PloS One 15:e0229769. https://doi.org/10.1371/journal.pone.0229769
Fusaro M, Tondolo F, Gasperoni L, Tripepi G, Plebani M, Zaninotto M, Nickolas TL, Ketteler M, Aghi A, Politi C, La Manna G (2022) The role of vitamin K in CKD-MBD. Curr Osteoporos Rep 20:65–77. https://doi.org/10.1007/s11914-022-00716-z
Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT (2009) A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc 19:504–510. https://doi.org/10.1016/j.numecd.2008.10.004
Gong X, Gutala R, Jaiswal AK (2008) Quinone oxidoreductases and vitamin K metabolism. Vitam Horm 78:85–101. https://doi.org/10.1016/S0083-6729(07)00005-2
Hadipour E, Tayarani-Najaran Z, Fereidoni M (2020) Vitamin K2 protects PC12 cells against Aβ (1–42) and H2O2-induced apoptosis via p38 MAP kinase pathway. Nutr Neurosci 23:343–352. https://doi.org/10.1080/1028415X.2018.1504428
Hamidi MS, Gajic-Veljanoski O, Cheung AM (2013) Vitamin K and bone health. J Clin Densitom 16:409–413. https://doi.org/10.1016/j.jocd.2013.08.017
Harrington DJ, Soper R, Edwards C, Savidge GF, Hodges SJ, Shearer MJ (2005) Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 46:1053–1060. https://doi.org/10.1194/jlr.D400033-JLR200
Hijaz BA, Volpicelli-Daley LA (2020) Initiation and propagation of α-synuclein aggregation in the nervous system. Mol Neurodegeneration 15:19. https://doi.org/10.1186/s13024-020-00368-6
Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H (2007) Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int 18:251–259. https://doi.org/10.1007/s00198-006-0282-z
Huang SH, Fang ST, Chen YC (2021) Molecular mechanism of Vitamin K2 protection against amyloid-β-induced cytotoxicity. Biomolecules 11:423. https://doi.org/10.3390/biom11030423
Hung YJ, Lee CH, Chu NF, Shieh YS (2010) Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 33:1840–1844. https://doi.org/10.2337/dc09-1073
Husain H, Scur M, Murtuza A, Bui N, Woodward B, Kurzrock R (2017) Strategies to overcome bypass mechanisms mediating clinical resistance to EGFR tyrosine kinase inhibition in lung cancer. Mol Cancer Ther 16:265–272. https://doi.org/10.1158/1535-7163.MCT-16-0105
Hussein AG, Mohamed RH, Shalaby SM, Abd El Motteleb DM (2018) Vitamin K2 alleviates type 2 diabetes in rats by induction of osteocalcin gene expression. Nutrition 47:33–38. https://doi.org/10.1016/j.nut.2017.09.016
Ikeda Y, Iki M, Morita A, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H (2006) Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) study. J Nutr 136:1323–1328. https://doi.org/10.1093/jn/136.5.1323
Indyk HE, Shearer MJ, Woollard DC (2016) Vitamin K: properties and determination. Encyclopedia of Food and Health 5:430–435. https://doi.org/10.1016/B978-0-12-384947-2.00728-5
Ishimoto Y, Ohashi K, Mizuno K, Nakano T (2000) Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, Gas 6. J Biol Chem 127:411–417. 127:411-7
Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK (2019) Plant extracts and phytochemicals targeting α-synuclein aggregation in Parkinson’s disease models. Front Pharmacol 9:1555. https://doi.org/10.3389/fphar.2018.01555
Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, Raychaudhuri S, de Bakker PI (2013) Imputing amino acid polymorphisms in human leukocyte antigens. PloS One 8:e64683. https://doi.org/10.1371/journal.pone.0064683
Jiang Y, Zhang ZL, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW (2014) Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial. Clin Interv Aging 9:121. https://doi.org/10.2147/CIA.S54107
Jin CW, Wang H, Chen YQ, Tang MX, Fan GQ, Wang ZH, Li L, Zhang Y, Zhang W, Zhong M (2015) Gas 6 delays senescence in vascular smooth muscle cells through the PI3K/Akt/FoxO signaling pathway. Cell Physiol Biochem 35:1151–1166. https://doi.org/10.1159/000373940
Kaneki M, Hedges SJ, Hosoi T, Fujiwara S, Lyons A, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S (2001) Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17:315–321. https://doi.org/10.1016/S0899-9007(00)00554-2
Karsenty G, Oury F (2014) Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol 382:521–526. https://doi.org/10.1016/j.mce.2013.10.008
Kiely M, Hodgins SJ, Merrigan BA, Tormey S, Kiely PA, O’Connor EM (2015) Real-time cell analysis of the inhibitory effect of vitamin K2 on adhesion and proliferation of breast cancer cells. Nutr Res 35:736–743. https://doi.org/10.1016/j.nutres.2015.05.014
Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E (2013) Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int 24:2499–2507. https://doi.org/10.1007/s00198-013-2325-6
Krueger T, Westenfeld R, Ketteler M, Schurgers LJ, Floege J (2009) Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 76:18–22. https://doi.org/10.1038/ki.2009.126
Krzyżanowska P, Drzymała-Czyż S, Pogorzelski A, Duś-Żuchowska M, Skorupa W, Bober L, Sapiejka E, Oralewska B, Rohovyk N, Moczko J, Nowak J (2017) Vitamin K status in cystic fibrosis patients with liver cirrhosis. Dig Liver Dis 49:672–675. https://doi.org/10.1016/j.dld.2017.01.155
Lasemi R, Kundi M, Moghadam NB, Moshammer H, Hainfellner JA (2018) Vitamin K2 in multiple sclerosis patients. Wien Klin Wochenschr 130:307–313. https://doi.org/10.1007/s00508-018-1328-x
Lee IJ, Hilliard B, Swami A, Madara JC, Rao S, Patel T, Gaughan JP, Lee J, Gadegbeku CA, Choi ET, Cohen PL (2012) Growth arrest-specific gene 6 (Gas 6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant 27:4166–4172. https://doi.org/10.1093/ndt/gfs337
Limbocker R, Errico S, Barbut D, Knowles TP, Vendruscolo M, Chiti F, Zasloff M (2022) Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic. Nat Prod Rep 39:742–753. https://doi.org/10.1039/D1NP00042J
Lin R, Charlesworth J, van der Mei I, Taylor BV (2012) The genetics of multiple sclerosis. Pract Neurol 12:279–288. https://doi.org/10.1136/practneurol-2012-000276
Lindholt JS, Frandsen NE, Fredgart MH, Øvrehus KA, Dahl JS, Møller JE, Folkestad L, Urbonaviciene G, Becker SW, Lambrechtsen J, Auscher S (2018) Effects of menaquinone-7 supplementation in patients with aortic valve calcification: study protocol for a randomized controlled trial. BMJ Open 8:e022019. https://doi.org/10.1136/bmjopen-2018-022019
Loges S, Schmidt T, Tjwa M, Van Geyte K, Lievens D, Lutgens E, Vanhoutte D, Borgel D, Plaisance S, Hoylaerts M, Luttun A (2010) Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas 6. Blood Am J Hematol 115:2264–2273. https://doi.org/10.1182/blood-2009-06-228684
Lombardi G, Perego S, Luzi L, Banfi G (2015) A four-season molecule: osteocalcin. Updates in Its Physiological Roles Endocrine 48:394–404. https://doi.org/10.1007/s12020-014-0401-0
Maillard CH, Berruyer MI, Serre CM, Dechavanne MA, Delmas PD (1992) Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 130:1599–1604. https://doi.org/10.1210/endo.130.3.1531628
McCann JC, Ames BN (2009) Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 90:889–907. https://doi.org/10.3945/ajcn.2009.27930
Melaragno MG, Cavet ME, Yan C, Tai LK, Jin ZG, Haendeler J, Berk BC (2004) Gas 6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. J Mol Cell Cardiol 37:881–887. https://doi.org/10.1016/j.yjmcc.2004.06.018
Miljković D, Spasojević I (2013) Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 19:2286–2334. https://doi.org/10.1089/ars.2012.5068
Mizuta T, Ozaki I, Eguchi Y, Yasutake T, Kawazoe S, Fujimoto K, Yamamoto K (2006) The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer 106:867–872. https://doi.org/10.1002/cncr.21667
Moriya M, Nakatsuji Y, Okuno T, Hamasaki T, Sawada M, Sakoda S (2005) Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol 170:11–20. https://doi.org/10.1016/j.jneuroim.2005.08.001
Myneni VD, Mezey E (2017) Regulation of bone remodeling by vitamin K2. Oral Dis 23:1021–1028. https://doi.org/10.1111/odi.12624
Nagai K, Miyoshi M, Kake T, Fukushima N, Matsuura M, Shibata E, Yamada S, Yoshikawa K, Kanayama HO, Fukawa T, Yamaguchi K (2013) Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy. PloS One 8:e66759. https://doi.org/10.1371/journal.pone.0066759
Nichols E, Szoeke CE, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, Aichour MT, Akinyemi RO, Alahdab F, Asgedom SW, Awasthi A (2019) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:88–106. https://doi.org/10.1016/S1474-4422(18)30403-4
Niemiec A, Stasiak U, Wasilewska A, Przybylski D, Marchelek-Myśliwiec M, Nowosiad-Magda M (2020) Multi-faceted function of vitamin K with particular consideration of vitamin K2–literature review. Pomeranian J Life Sci 66:39–44. https://doi.org/10.21164/pomjlifesci.477
Novitskiy SV, Zaynagetdinov R, Vasiukov G, Gutor S, Han W, Serezani A, Matafonov A, Gleaves LA, Sherrill TP, Polosukhin VV, Blackwell TS (2019) Gas 6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis. Oncotarget 10:7031. https://doi.org/10.18632%2Foncotarget.27345
Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M, Nakagawa K (2008) Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 283:11270–11279. https://doi.org/10.1074/jbc.M702971200
Oldenburg J, Marinova M, Müller-Reible C, Watzka M (2008) The vitamin K cycle. Vitam Horm 78:35–62. https://doi.org/10.1016/S0083-6729(07)00003-9
Orlando A, Linsalata M, Tutino V, D'Attoma B, Notarnicola M, Russo F (2015) Vitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines. Biomed Res Int 2015:296721. https://doi.org/10.1155/2015/296721
Palermo A, Tuccinardi D, D’Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R, Napoli N, Pozzilli P, Manfrini S (2017) Vitamin K and osteoporosis: myth or reality? Metabolism 70:57–71. https://doi.org/10.1016/j.metabol.2017.01.032
Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, Cronin SJ (2014) The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature 507:508–512. https://doi.org/10.1038/nature12998
Pereira SP, Rowbotham D, Fitt S, Shearer MJ, Wendon J, & Williams R (2005) Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease J Hepatol 42:365–370. https://doi.org/10.1016/j.jhep.2004.11.030
Puzantian H, Akers SR, Oldland G, Javaid K, Miller R, Ge Y, Ansari B, Lee J, Suri A, Hasmath Z, Townsend R (2018) Circulating dephospho-uncarboxylated matrix Gla-protein is associated with kidney dysfunction and arterial stiffness. Am J Hypertens 31:988–994. https://doi.org/10.1093/ajh/hpy079
Rahimi Sakak F, Moslehi N, Niroomand M, Mirmiran P (2021) Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial. Eur J Nutr 60:2495–2506. https://doi.org/10.1007/s00394-020-02419-6
Ramazani E, Fereidoni M, Tayarani-Najaran Z (2019) Protective effects of vitamin K2 on 6-OHDA-induced apoptosis in PC12 cells through modulation Bax and caspase-3 activation. Mol Biol Rep 46:5777–5783. https://doi.org/10.1007/s11033-019-05011-2
Ribbons KA, McElduff P, Boz C, Trojano M, Izquierdo G, Duquette P, Girard M, Grand’Maison F, Hupperts R, Grammond P, Oreja-Guevara C (2015) Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PloS One 10:e0122686. https://doi.org/10.1371/journal.pone.0122686
Sarkar SR, Banerjee S (2019) Gut microbiota in neurodegenerative disorders. J Neuroimmunol 328:98–104. https://doi.org/10.1016/j.jneuroim.2019.01.004
Savitt D, Jankovic J (2019) Targeting α-synuclein in Parkinson’s disease: progress towards the development of disease-modifying therapeutics. Drugs 79:797–810. https://doi.org/10.1007/s40265-019-01104-1
Scaglione F (2013) New oral anticoagulants: comparative pharmacology with vitamin K antagonists. Clin Pharmacokinet 52:69–82. https://doi.org/10.1007/s40262-012-0030-9
Schurgers LJ, Vermeer C (2000) Determination of phylloquinone and menaquinones in food. Pathophysiol Haemost Thromb 30:298–307. https://doi.org/10.1159/000054147
Schurgers LJ, Vermeer C (2002) Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta Gen Subj 1570:27–32. https://doi.org/10.1016/S0304-4165(02)00147-2
Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C (2007) Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 109:3279–3283. https://doi.org/10.1182/blood-2006-08-040709
Schwalfenberg GK (2017) Vitamins K1 and K2: the emerging group of vitamins required for human health. J Nutr Metab 2017:6254836. https://doi.org/10.1155/2017/6254836
Shiraki M, Yamazaki Y, Shiraki Y, Hosoi T, Tsugawa N, Okano T (2010) High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. J Bone Miner Metab 28:578–584. https://doi.org/10.1007/s00774-010-0167-2
Silaghi CN, Ilyés T, Filip VP, Farcaș M, van Ballegooijen AJ, Crăciun AM (2019) Vitamin K dependent proteins in kidney disease. Int J Mol Sci 20:1571. https://doi.org/10.3390/ijms20071571
Suhara Y, Wada A, Okano T (2009) Elucidation of the mechanism producing menaquinone-4 in osteoblastic cells. Bioorg Med Chem Lett 19:1054–1057. https://doi.org/10.1016/j.bmcl.2009.01.021
Theuwissen E, Smit E, Vermeer C (2012) The role of vitamin K in soft-tissue calcification. Adv Nutr 3:166–173. https://doi.org/10.3945/an.111.001628
Tian W, Wang L, Yuan L, Duan W, Zhao W, Wang S, Zhang Q (2016) A prognostic risk model for patients with triple-negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6. Cancer Sci 107:882–889. https://doi.org/10.1111/cas.12964
Tjwa M, Moons L, Lutgens E (2009) Pleiotropic role of growth arrest-specific gene 6 in atherosclerosis. Curr Opin Lipidol 20:386–392. https://doi.org/10.1097/MOL.0b013e328330982e
van der Meer JH, van der Poll T, van ‘t Veer C, (2014) TAM receptors, Gas 6, and protein S: roles in inflammation and hemostasis. Blood 123:2460–2469. https://doi.org/10.1182/blood-2013-09-528752
Vissers LE, Dalmeijer GW, Boer JM, Verschuren WM, van der Schouw YT, Beulens JW (2016) The relationship between vitamin K and peripheral arterial disease. Atherosclerosis 252:15–20. https://doi.org/10.1016/j.atherosclerosis.2016.07.915
Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ (2006) Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 48:392–401. https://doi.org/10.1053/j.ajkd.2006.05.021
Wen L, Chen J, Duan L, Li S (2018) Vitamin K dependent proteins involved in bone and cardiovascular health. Mol Med Rep 18:3–15. https://doi.org/10.3892/mmr.2018.8940
Wootla B, Eriguchi M, Rodriguez M (2012) Is multiple sclerosis an autoimmune disease? Autoimmune Dis 2012:969657. https://doi.org/10.1155/2012/969657
Wu CS, Hu CY, Tsai HF, Chyuan IT, Chan CJ, Chang SK, Hsu PN (2014) Elevated serum level of growth arrest-specific protein 6 (Gas 6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis. Rheumatol Int 34:625–629. https://doi.org/10.1007/s00296-013-2882-1
Wu G, Ma Z, Cheng Y, Hu W, Deng C, Jiang S, Li T, Chen F, Yang Y (2018) Targeting Gas 6/TAM in cancer cells and tumor microenvironment. Mol Cancer 17:20. https://doi.org/10.1186/s12943-018-0769-1
Wyskida K, Żak-Gołąb A, Łabuzek K, Suchy D, Ficek R, Pośpiech K, Olszanecka-Glinianowicz M, Okopień B, Więcek A, Chudek J (2015) Daily intake and serum concentration of menaquinone-4 (MK-4) in haemodialysis patients with chronic kidney disease. Clin Biochem 48:1246–1251. https://doi.org/10.1016/j.clinbiochem.2015.08.011
Xu W, Chen S, Wang X, Tahara K, Wu H, Tanaka S, Sugiyama K, Sawada T, Hirano T (2021) Suppressive effect of vitamin K2 against mitogen-activated peripheral blood mononuclear cells of rheumatoid arthritis patients. Int J Clin Pharmacol Ther 59:55–62. https://doi.org/10.5414/CP203827
Yu YX, Li YP, Gao F, Hu QS, Zhang Y, Chen D, Wang GH (2016) Vitamin K 2 suppresses rotenone-induced microglial activation in vitro. Acta Pharmacol Sin 37:1178–1189. https://doi.org/10.1038/aps.2016.68
Yu YX, Yu XD, Cheng QZ, Tang L, Shen MQ (2020) The association of serum vitamin K2 levels with Parkinson’s disease: from basic case-control study to big data mining analysis. Aging 12:16410–16419. 10.18632%2Faging.103691
Zhang X, Tao Y, Chopra M, Dujmovic-Basuroski I, Jin J, Tang Y, Drulovic J, Markovic-Please S (2015) IL-11 induces Th17 cell responses in patients with early relapsing-remitting multiple sclerosis. J Immunol 194:5139–5149. https://doi.org/10.4049/jimmunol.1401680
Zhang Y, Bala V, Mao Z, Chhonker YS, Murry DJ (2019) A concise review of quantification methods for determination of vitamin K in various biological matrices. J Pharm Biomed Anal 169:133–141. https://doi.org/10.1016/j.jpba.2019.03.006
Zhao YF, Xu DC, Zhu GF, Zhu MY, Tang K, Li WM, Xu YW (2016) Growth arrest–specific 6 exacerbates pressure overload–induced cardiac hypertrophy. Hypertension 67:118–129. https://doi.org/10.1161/HYPERTENSIONAHA.115.06254
Zhao GJ, Zheng JY, Bian JL, Chen LW, Dong N, Yu Y, Hong GL, Chandoo A, Yao YM, Lu ZQ (2017) Growth arrest-specific 6 enhances the suppressive function of CD4+ CD25+ regulatory T cells mainly through Axl receptor. Mediators Inflamm 2017:6848430. https://doi.org/10.1155/2017/6848430
Zuo PY, Chen XL, Lei YH, Liu CY, Liu YW (2014) Growth arrest-specific gene 6 protein promotes the proliferation and migration of endothelial progenitor cells through the PI3K/AKT signaling pathway. Int J Mol Med 34:299–306. https://doi.org/10.3892/ijmm.2014.1754
Author information
Authors and Affiliations
Contributions
KC developed the idea and was involved in the drafting and revision of the manuscript; PMM was involved in the drafting and revision of the manuscript; SB developed the idea and was involved in the drafting and revision of the manuscript. All authors have read and agreed the submission of the revised version of the manuscript.
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chatterjee, K., Mazumder, P.M. & Banerjee, S. Vitamin K: a Potential Neuroprotective Agent. Rev. Bras. Farmacogn. 33, 676–687 (2023). https://doi.org/10.1007/s43450-023-00378-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-023-00378-7